MATSEN LIFE SCIENCES
The computed 12-month bankruptcy probability of MATSEN LIFE SCIENCES is 0.3% (very low). The 2024 annual accounts show equity of €21k and a net result of €-61k. Equity is shrinking by ~31.1% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2026. Its solvency ranks better than 47% of 1234 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €21k |
| Net result | €-61k |
| Better than sector | 47% |
| Active | 4 yrs |
Fragile profile — watch profitability in particular.
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil–Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 66.2% | 68.2% | |
| Net result | €-61k | €40k | |
| Equity | €21k | €79k | |
| Gross operating margin | €-51k | €69k | |
| Total assets | €32k | €147k |
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | €-51k |
| Net profit | €-61k |
| Cash flow | €-54k |
| Staff costs | — |
| Income taxes | €213 |
| Dividends | — |
| Total assets | €32k |
| Equity | €21k |
| Debt | €11k |
| of which ≤ 1y | €11k |
| of which > 1y | — |
| Working capital | €-5k |
| Employees (FTE) | — |
| 2024 | |
|---|---|
| Current ratio | 0.59 |
| Quick ratio | 0.59 |
| Working capital ratio | -14.0% |
| Solvency | 66.2% |
| Debt / equity | 0.51 |
| Long-term debt ratio | — |
| Interest coverage | -22.04 |
| Gross margin | — |
| Net margin | — |
| ROA | -189.6% |
| ROE | -286.5% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €32k |
| Fixed assets | 21/28 | €26k |
| Tangible fixed assets | 22/27 | €26k |
| Current assets | 29/58 | €6k |
| Amounts receivable within one year | 40/41 | €2k |
| Cash & bank | 54/58 | €4k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €32k |
| Equity | 10/15 | €21k |
| Contributions / capital | 10/11 | €5k |
| Reserves | 13 | €78k |
| Accumulated profits (losses) | 14 | €-61k |
| Amounts payable | 17/49 | €11k |
| Amounts payable within one year | 42/48 | €11k |
| Trade debts payable within one year | 44 | €38 |
| Income statement | ||
| Gross operating margin | 9900 | €-51k |
| Operating result | 9901 | €-59k |
| Financial income | 75 | €3 |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €-61k |
| Income taxes | 67/77 | €213 |
| Net result for the period | 9904 | €-61k |
| Result to be appropriated | 9905 | €-61k |
| NACE primary | Human health(86910) |
| Legal form | Private limited company(610) |
| Incorporation | 04-03-2022 |
| Status | Active |
| Postal code | 1840 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23045C0048/00N000 | Flanders | 1,104 m² | 1 · 165 m² | 9.5 m · 2 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | MATSEN LIFE SCIENCES |